Steven C. Quay - 24 Feb 2022 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
President & CEO, Director
Signature
/s/ Steven Quay
Issuer symbol
ATOS
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 16:15:56 UTC
Previous filing
18 May 2021
Next filing
06 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +1,900,000 $0.000000 1,900,000 24 Feb 2022 Common Stock 1,900,000 $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest on a quarterly basis over two (2) years.